|Bid||267.26 x 1000|
|Ask||267.38 x 800|
|Day's Range||263.50 - 268.11|
|52 Week Range||211.71 - 288.46|
|Beta (5Y Monthly)||0.58|
|PE Ratio (TTM)||18.97|
|Earnings Date||Jan 29, 2024 - Feb 02, 2024|
|Forward Dividend & Yield||8.52 (3.21%)|
|Ex-Dividend Date||Nov 16, 2023|
|1y Target Est||277.83|
Subscribe to Yahoo Finance Plus to view Fair Value for AMGN
Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.
When investing in the stock market, a history of strong returns should be high on your priority list. Combine this with a positive outlook on the future, and you may have a winner to add to your portfolio. Amgen Inc., an American multinational biopharmaceutical company, fits this mold. The company has a 10-year annualized total return of 13.69% through the end of 2022. And if that's not enough to pique your interest, consider this: It pays out billions of dollars in dividends to investors every
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.